Full Coverage

IDRI Receives NIH Funding to Design Adjuvants to Improve New TB Vaccine Protection

                   
redorbit.com
26-Aug-2008
        
Story Timeline:  97 days

Posted on: Tuesday, 26 August 2008, 09:01 CDT SEATTLE, Aug. 26 /PRNewswire/ -- IDRI announced today it has been awarded a $6.3 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the development of adjuvant combinations specifically designed to enhance the immune response to new tuberculosis vaccine antigens. This four-year... [read full story]                    

Add Comment
Latest article on this story:

Infectious Disease Research Institute receives $6.3 million NIAID grant to study TB vaccine

 news-medical.net 29-Aug-2008
First article on this story:

Infectious Disease Research Institute receives $6.3 million NIAID grant to study TB vaccine

 news-medical.net 29-Aug-2008
Selected publications with coverage of this story:
redorbit.com news-medical.net
RELATED
No documents found.